8-KEarnings & ResultsRegulation FDExhibits & Filings

CENTENE CORP 8-K Report, Financial Results (Jan 11, 2016)

Filed January 11, 2016For Securities:CNC

Summary

Centene Corporation (CNC) filed this 8-K on January 11, 2016, primarily to announce its participation in the J.P. Morgan 34th Annual Healthcare conference. During this presentation, the company confirmed its previously issued financial guidance for both 2015 and 2016, which was initially provided at its Investor Day on December 18, 2015. Investors can access a copy of this guidance on Centene's investor relations website. The filing emphasizes that the company does not undertake to update its earnings guidance outside of its regular quarterly or yearly earnings disclosures, and any silence regarding guidance should not be interpreted as a change. Furthermore, Centene is proactively informing investors and stakeholders about its intention to utilize its investor relations website as a channel for disseminating important company information, including potentially material updates. This aligns with SEC guidance on website disclosures and encourages continuous engagement with the company's SEC filings, press releases, conference calls, and webcasts for a comprehensive view of company developments. The information presented here is not considered "filed" for regulatory purposes, meaning it does not carry the same liability as traditional filings under Section 18 of the Securities Exchange Act of 1934.

Key Highlights

  • 1Centene participated in the J.P. Morgan 34th Annual Healthcare conference on January 11, 2016.
  • 2The company confirmed its previously announced 2015 and 2016 financial guidance.
  • 3Guidance was initially provided at the Investor Day on December 18, 2015.
  • 4Investors can access the guidance details on Centene's investor relations website.
  • 5Centene will not provide updates on earnings guidance outside of regular reporting cycles.
  • 6The company intends to use its investor relations website to publish important and potentially material information.
  • 7Information in this filing is not deemed 'filed' for Section 18 liability purposes.

Frequently Asked Questions

The main purpose of this 8-K filing was to inform investors about Centene's participation in the J.P. Morgan 34th Annual Healthcare conference and to confirm its previously issued 2015 and 2016 financial guidance.

The detailed financial guidance for 2015 and 2016, which was confirmed at the J.P. Morgan conference, can be found on Centene's investor relations website. A copy was also available at the company's Investor Day on December 18, 2015.

No, Centene explicitly states that it undertakes no obligation to update its earnings guidance outside of its regular quarterly or yearly earnings disclosures. Silence on guidance should not be interpreted as a change.

Centene intends to use its investor relations website to publish important information about the company, including potentially material updates. Investors are encouraged to monitor this website in addition to traditional SEC filings, press releases, conference calls, and webcasts.